Last reviewed · How we verify

ACYC vehicle — Competitive Intelligence Brief

ACYC vehicle (ACYC vehicle) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiviral agent (topical formulation). Area: Virology/Dermatology.

phase 3 Antiviral agent (topical formulation) Viral DNA polymerase (via acyclovir active ingredient) Virology/Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

ACYC vehicle (ACYC vehicle) — Bausch Health Americas, Inc.. ACYC vehicle is a topical formulation designed to enhance the delivery and efficacy of acyclovir for localized antiviral treatment.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ACYC vehicle TARGET ACYC vehicle Bausch Health Americas, Inc. phase 3 Antiviral agent (topical formulation) Viral DNA polymerase (via acyclovir active ingredient)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiviral agent (topical formulation) class)

  1. Bausch Health Americas, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ACYC vehicle — Competitive Intelligence Brief. https://druglandscape.com/ci/acyc-vehicle. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing